Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Stomach Neoplasms × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 37 Prostatic Neoplasms 19 Multiple Myeloma 17 Neoplasm Metastasis 14 Osteoporosis 8 Neuroblastoma 6 Pain 5 Osteosarcoma 5 Neoplasms, Plasma Cell 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Lung Neoplasms 4 Carcinoma, Renal Cell 4 Sarcoma, Ewing 3 Bone Diseases, Metabolic 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Osteonecrosis 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Kidney Neoplasms 2 Humoral Hypercalcemia Of Malignancy 2 Giant Cell Tumor of Bone 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Adenocarcinoma 2

Interventions

Oxaliplatin 200 Capecitabine 116 S 1 (combination) 105 Fluorouracil 105 Docetaxel 100 Cisplatin 88 Leucovorin 75 Paclitaxel 70 Irinotecan 68 apatinib 43 sintilimab 42 Drug Therapy 40 Surgical Procedures, Operative 37 Hyperthermic Intraperitoneal Chemotherapy 34 pembrolizumab 32 Radiotherapy 31 Trastuzumab 30 Gastrectomy 23 Epirubicin 22 Tegafur 21 Nivolumab 21 Bevacizumab 21 XELOX 20 titanium silicide 19 camrelizumab 19 tislelizumab 17 Ramucirumab 17 Carboplatin 16 Endoscopic Mucosal Resection 15 Albumin-Bound Paclitaxel 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06759064 2025-11-19

IPIZA

Qilu Hospital of Shandong University

Phase 1/2 Recruiting

Gastrointestinal

Adenocarcinoma, Ascites, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡